Subscribe to Search results

In a letter to Dr Gunson, Professor Cash proposed delaying any lookback programme until further UK deliberations had taken place.

Published on:

In a letter to Professor Cash, Dr Gunson noted the RTCs did not have access to anti-HCV testing material, and recommended usual investigations in reported cases involving a transfusion-associated NANBH.

Published on:

Dr Keel wrote to Professor Franklin to discuss the HCV lookback exercise in 1998, and noted it could not be considered formally closed until reasons for non-traceability of components or recipients were logged on the lookback register.

Published on:

Professor Cash wrote to Dr Jack Gillon to discuss the Medical & Scientific Committee agreement to use donor counselling guidelines in leaflet form within RTCs.

Published on:

A letter from Professor Bloom and Dr Rizza to Haemophilia centre directors stated that many directors reserved supplies of cryoprecipitate for the treatment of children.

Published on:

In his oral evidence, Dr Winter agreed that whilst cryoprecipitate was more laborious to use, it could be used, and had been used, to raise Factor 8 levels. Side effects were for the most part transient.

Published on:

In an article Dr Biggs said: "Cryoprecipitate is a simple concentrate made from plasma at all Regional Transfusion Centres. Cryoprecipitate is much superior to plasma for the treatment of haemophilia A patients but the material is very variable from one sample to another and the potency cannot be known before it is used."

Published on:

Porcine plasma was first used to treat a patient in 1954.

Published on:

Early in the Second World War, Dr Edwin Cohn had developed ways of separating plasma into separate protein fractions, by treating whole blood with anticoagulant, separating off the plasma, and "fractionating" the plasma under varying conditions of acidity and proportions of ethanol so as to separate one fraction of it from another.

Published on:

Professor Pier Manucci wrote in The Lancet that desmopressin could be "a promising pharmacological alternative to plasma concentrates in the management of some patients with haemophilia and vWd."

Published on:

The BMA published a revised ethics handbook - Philosophy & Practice of Medical Ethics. This discussed consent, and the underlying ethical principles, in more detail than previous handbooks.

Published on:

The British Medical Association published guidance entitled Medical Ethics which described the relationship between a doctor and their patient "as that of absolute confidence and mutual respect."

Published on:

The BMA published its Handbook of Medical Ethics which expressly addressed consent to treatment: "Consent is valid when freely given if the patient understands the nature and consequences of what is proposed. Assumed consent or consent obtained by undue influence is valueless."

Published on:

An amended version of the Handbook of Medical Ethics was published and added regarding consent that "Doctors offer advice but it is the patient who decides whether or not to accept the advice.

Published on:

Medical Ethics Today: Its Practice and Philosophy referred to the relationship between doctor and patient as: "based on the concept of partnership and collaborative effort...the basic premise is that treatment is undertaken as a result of patients being actively involved in deciding what is to be done to them".

Published on:

The Medical Defence Union's guidance on Consent to Operative Treatment noted that the patient "should be given a fair and reasonable explanation, in non-technical language, of the effect and nature of the operation...If the operation contemplated carries special risks, which are probably unknown to the patient, he should, as a general rule, be informed of these risks".

Published on:

The Medical Defence Union's memorandum Consent To Treatment began with a quotation from a 1912 decision by the US courts: "No amount of professional skill can justify the substitution of the will of the surgeon for that of his patient".

Published on:

The GMC published its first specific guidance on consent in November 1998: Seeking patients' consent: the ethical considerations.

Published on:

The Expert Report to the Infected Blood Inquiry on Medical Ethics described the principle of autonomy regarding the patient's consent.

Published on:

The Medical Ethics Expert Panel told the Inquiry that consent must be informed: in other words, the patient must have been given sufficient information about the risks and benefits of treatment, alternative treatments and the right to refuse treatment.

Published on: